Even in cases of diffuse diabetic macular edema not responding to previous treatments such as photocoagulation, intravitreal injection of triamcinolone, or vitrectomy, improvement of visual acuity and decrease of retinal thickness could be observed after intravitreal injection of bevacizumab. Although our follow-up period was too short to provide specific treatment recommendations, the short-term results encourage further prospective studies with different treatment groups and longer follow-up.

PURPOSE. To assess the suitability of corneal anterior and posterior surface aberrations and thickness profile data for discrimination between eyes with early keratoconus (KC), fellow eyes of eyes with early KC, and normal eyes. METHODS. Thirty-two eyes (group 1) of 25 patients were newly diagnosed with KC; 17 eyes of 17 patients (group 2) were asymptomatic fellow eyes without clinical signs of KC. One hundred twenty-three healthy eyes of 69 patients were negative control eyes (group 3). Zernike coefficients from anterior and posterior surfaces, data from corneal thickness spatial profiles, and output values of discriminant functions based on wavefront and pachymetry data were assessed by receiver operating characteristic (ROC) curve analysis for their usefulness in discriminating between KC (groups 1, 2) eyes and control eyes. RESULTS. Vertical coma (C(3)(-1)) from the anterior surface was the coefficient with the highest ability to discriminate between groups 2 and 3 (area under the ROC curve [A(z)ROC] = 0.980; cutoff, -0.2 microm). For posterior wavefront coefficients and pachymetry data, A(z)ROC values were lower. Constructing discriminant functions from Zernike coefficients increased A(z)ROC values. The function containing first-surface data reached an A(z)ROC of 0.993; the functions containing posterior surface or pachymetry data had lower A(z)ROC values (0.932 and 0.903, respectively). The function with anterior, posterior, and pachymetry data reached an A(z)ROC of 1.0. CONCLUSIONS. Corneal wavefront and pachymetry data enabled highly accurate distinction of eyes with subclinical keratoconus from normal eyes. Posterior aberrations and thickness spatial profile data did not markedly improve discriminative ability over that of anterior wavefront data alone.

TGF-beta 2 is capable of inducing the expression of ECM and basement membrane components in cultured ONH astrocytes via CTGF and upregulated TSP-1, a protein naturally involved in the activation of latent TGF-beta. Therefore, TGF-beta 2 could be a factor in the initiation of the modification of ECM in the glaucomatous ONH. In addition, TSP-1 induction may be a mechanism by which TGF-beta 2 amplifies its own activation.

The IOP correction process developed in this study was successful in reducing reliance of IOP measurements on both corneal thickness and age in a healthy European population.

The data demonstrate that quercetin is able to protect RPE cells from oxidative damage and cellular senescence in vitro in a dose-dependent manner. The authors suggest that this increase in antioxidative capacity is--among other mechanisms, such as the intracellular redox state--also mediated by inhibiting the upregulation of caveolin-1. Downregulation of caveolin-1 may be important for the retinal pigment epithelium to prevent apoptotic cell death in response to cellular stress, a condition implicated in the early pathogenesis of AMD. Therefore, the authors believe that the use of antioxidative dietary flavonoids such as quercetin is a promising approach in the prevention of early AMD.

Even in cases with chronic diffuse ischemic diabetic macular edema, a long-term decrease of central retinal thickness can be observed following repeated intravitreal injections of bevacizumab. In these patients, mean decrease in retinal thickness is aligned with a gain in mean VA. Treatment with bevacizumab at an earlier stage of diabetic macular edema without ischemia may be associated with an even better functional outcome.

Intravitreal injection of bevacizumab appears to be a new treatment option for patients with macular edema secondary to CRVO.

In this 2-part overview, the current status of phakic intraocular lens (pIOL) surgery to correct refractive errors is reviewed. Three types of pIOLs, categorized by their intraocular position, are included: angle-supported anterior chamber, iris-fixated anterior chamber, and posterior chamber (usually fixated in the ciliary sulcus). Part 1 reviews the main models of each pIOL type, the selection criteria, and the surgical techniques, with emphasis on currently available pIOLs. Bioptics, adjustable refractive surgery, and enhancements are addressed, and applications of the new anterior segment imaging techniques are reviewed.